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Background Hemorrhagic portal hypertension, sec-
ondary to both intrahepatic and extrahepatic portal
hypertension, is an uncommon entity. In this condi-
tion, the extrahepatic and the intrahepatic obstruc-
tion of the portal vein, due to chronic liver disease,
produce a more severe form of hemorrhagic portal
hypertension that is more difficult to control. The
results of surgical treatment (modified Sugiura-
Futagawa operation) in this subset of patients is
analyzed.
Methods Among 714 patients with a history of
hemorrhagic portal hypertension, 14 cases were
found with histologically proven liver cirrhosis
and complete splenomesoportal thrombosis demon-
strated by means of preoperative angiography.
Patients with incomplete (partial) splenomesoportal
thrombosis were excluded. There were nine males
and 5 females with a mean age of 51 years. Alcoholic
cirrhosis was demonstrated in 50% of the cases, post
hepatitic cirrhosis in 28%, primary biliary cirrhosis
in 7%, and cryptogenic cirrhosis in 14%. There were
nine Child-Pugh A and 5 B cases. All cases were
treated by means of our modified Sugiura-Futagawa
procedure.
Results Bleeding recurrence from esophagogastric
varices was shown in one case, colonic varices in one
case and hypertensive gastropathy in another of the
survivors. Post operative encephalopathy was
shown in 3 of the cases. The thirty-six month
survival rate was 30% (Kaplan-Meier).
Conclusions The combination of intrahepatic plus
extrahepatic portal hypertension has a worse prog-
nosis. Treatment options are limited (sclerotherapy
and/or devascularization), because shunt surgery,
TIPS and liver transplantation have a very restricted
role and postoperative outcome is poor.
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INTRODUCTION
Controversy exists between reports regarding
the association of portal vein thrombosis and
liver cirrhosis. Some authors state that about
10% of the patients with hepatic cirrhosis have
portal vein thrombosis. Okuda et al., found in an
autopsy study of liver cirrhosis that the inci-
dence of portal vein thrombosis in non splenec-
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tomized patients with cirrhosis was 0.6%. Of the
patients with portal vein thrombosis, about 25%
were cirrhotic [1, 2].
Hemorrhagic portal hypertension in patients
with liver cirrhosis and portal vein thrombosis,
represents a challenge for therapeutic efforts.
These patients have a mixed etiology of portal
hypertension: sinusoidal component of portal
hypertension due to liver cirrhosis and extra-
hepatic portal hypertension due to portal vein
thrombosis.
Here, we report the results of the surgical
treatment in patients with an uncommon etiol-
ogy of portal hypertension.
MATERIAL AND METHODS
Among 714 surgically treated patients with
hemorrhagic portal hypertension in a 23 year
period, the cases with histologically proven liver
cirrhosis and angiographic evidence of portal
vein thrombosis were selected. Portal vein
thrombosis was demonstrated by angiography
(celiac and mesenteric). The cases considered for
this study were those in which total disappear-
ance of the splenomesenteric and portal vein
was demonstrated. Cases in which the portal
vein was found with small diameter and/or
intraluminal defects but still patent, were not
included in the analysis.
Patients with hemorrhagic portal hyperten-
sion in the acute episode are treated by means of
sclerotherapy and/or pharmacotherapy. Pa-
tients in the bleeding-free interval and with
bleeding history in the last 6 months are
considered for surgical treatment if they are in
the low-risk group (Child-Pugh A-B cases).
Patients with bad liver function (Child-Pugh C)
are treated with other forms of therapy, i.e.,
chronic sclerotherapy, B-blockers and in selected
cases, intrahepatic portosystemic shunts. Some
of these cases are considered for the liver
transplant program. Our liver transplant pro-
gram is small, doing no more than 5 cases per
year. Patients with no patent portal vein are
excluded from our program. Angiographic
evaluation of the splanchnic area is a routine in
all of our surgical patients, in order to decide on
the type of surgery. Patients with adequate
vessels are considered for shunt surgery (selec-
tive shunts and, in very selected cases, for low-
diameter shunts). Patients with inadequate
vessels are considered for our modification of
the Sugiura-Futagawa operation.
In this operation an extensive devasculariza-
tion of the esophagogastric area is performed. It
is usually done in two stages (thoracic ..and
abdominal). The abdominal stage is completed
in the first operation. Devascularization of the
stomach with ablation of left gastroepiploic vein,
short gastric vessels and left coronary vein is
done with interruption of the communication
between the left and right gastric veins. A truncal
vagotomy is done, as well as a pylorophlasty in
order to prevent gastric retention. The spleen is
preserved if severe hypersplenism is not demon-
strated or if the patient does not have a very large
spleen. In the thoracic stage, devascularization of
the esophagus is done with transection in the
lower third (approximately at one inch of the
gastroesophageal junction). In the abdominal
stage a liver biopsy is routinely obtained.
RESULTS (TABLE I)
A total of 14 cases that met the above criteria
were analyzed. Most of them were low-risk
cases and liver cirrhosis was seen at macroscopic
inspection while operating. Histological confir-
mation was also obtained in all cases. In all
patients a liver biopsy was done in the abdom-
inal stage. Liver cirrhosis from different etiolo-
gies was shown. Alcohol-related cirrhosis was
demonstrated in 50% of the cases.
Preoperative splanchnic angiography showed
thrombosis of the splenomesenteric and portal
systems. Some of the cases had evidence of
recanalized thrombosis, but an inadequate dia-o 0 t160 M.A. MERCADO et al.
meter and blood flow were demonstrated. No
vessel was found with which to perform a
portosystemic shunt. This is why, all of the
patients were treated by means of our modifica-
tion of the Sugiura-Fatagawa operation. In 9
cases (7 Child-Pugh A, 2 B) the complete
operation was done (two stages, abdominal
and thoracic). In 5 cases, only the abdominal
stage was done. Three of these cases died
because of postoperative liver failure. The other
two cases were lost to follow-up and the
operation could not be completed.
From the 9 survivors with the complete
procedure, the following data were obtained.
Re-bleeding
Three of the patients had re-bleeding, one
because of esophagocardial varices one because
of colonic varices and the other because of
hypertensive gastropathy. Thus, global bleeding
recurrence was 33%, but from esophagogastric
varices it was 11%.
Encephalopathy
This was assessed by means of clinical evaluation
(including number connection tests) and was
demonstrated in 3 cases; grade II- III in two cases
and grade I in one case. Excluding patients with
operative mortality and those lost for follow-up,
the encephalopathy frequency was 33%.
Survival
This was calculated by means of the Kaplan-
Meier method. Survival was 30% at 36 months.
Table I shows the individualized outcome of the
patients.
DISCUSSION
Hemorrhagic portal hypertension, with an intra
and extrahepatic component, is a rare condition.
It represents only 2% of the cases operated in our
hospital. According to Okuda et al., portal vein
thrombosis in cirrhotic patients is also a rare
condition with a very low frequency in the
Japanese population. Although some interesting
explanations of the etiology have been given, the
exact physiopathology is unknown. Certainly
the flow alterations in the portal vein secondary
to hypertension and possibly the underlying
liver disease may play a role [3]. Also the kind of
thrombus and its evolution may differs from one
patient to another [4].
To our knowledge, the treatment results with
devascularization procedures in this subset of
patients have not been previously reported.
The combination of liver cirrhosis and sple-
nomesoportal system thrombosis represents 2%
of cases from our surgically treated population.
These had splenic mesenteric and portal veins
unsuitable for shunting, with chronic obstruc-
tion. The veins were tortuous, with a critical
reduction of their diameter, showing a small
lumen and not appropriate for any kind of shunt
(total, selective or low diameter). Under these
circumstances, to perform a shunt is not ad-
visable. For these cases, we believe devasculari-
zation procedures (modified Sugiura-Futagawa
operation) do not have good long term results.
In this series, the frequency of recurrent
bleeding was 33% as well as the frequency of
encephalopathy, the survival rate was low.
These results are different when compared to
those obtained in low risk patients (Child A-B)
in which usually a low rebleeding rate (10%) and
postoperative encephalopathy (4-7%), as well
as a good long term survival is obtained [5-9].
In the cirrothic-thrombotic patient a higher
operative mortality has been reported, we think
that this is the result of a more complex
operation with a higher degree of technical
difficulty. The devascularization is difficult due
to the collateral circulation and higher intraope-
rative bleeding with an increased requirement
for intraoperative blood products. In our experi-
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time, promotes a poor postoperative outcome; it
has also been our experience that these cases
more frequently develop liver failure and multi-
organ failure as well as postoperative coagulo-
pathy.
It may be that the mixed etiology, (intra and
extra hepatic) of the portal hypertension plays a
role in the poor outcome. For patients with a non
cirrhotic liver and extrahepatic portal hyperten-
sion, collaterals, have an hepatopetal flow
tendency, because the liver represents a low-
resistance vascular area. In the cases analyzed in
this paper, the liver represents a high resistance
area, and this is why more portosystemic
collaterals are promoted, explaining the high
encephalopathy rate and the neoformation of
esophageal and gastric varices after the devas-
cularization. This translates in to a higher
rebleeding rate.
These cases represent a challenge for the
treatment of hemorrhagic portal hypertension
and other therapy choices have also a limited role.
Pharmacotherapy for secondary prophylaxis has
a high rebleeding rate in all subsets of patients
with portal hypertension. Transendoscopic scle-
rotherapy and/or banding is one of the choices,
but a high rebleeding rate is to be expected [11].
No data is available in the literature in the
cirrhotic-thrombosed subset of patients.
A shunt can not be done safely in these cases,
because an adequate vessels can not be found to
perform either a total, selective or low diameter
shunt; in selected cases a makeshift shunt can be
performed with one dilated vein found in the
splanchnic area [12], but they have a high
dysfunction rate and obstruction can be ex-
pected in most of them.
Liver transplantation represents a challenge
for the surgeon in these patients. Nevertheless,
there are cases in which a thrombectomy of the
portal vein and/or a bypass of the recipient
mesenteric vein to the donor portal vein is
achievable [13].
Although some successful cases with portal
vein thrombosis treated by means of transjugu-
lar shunts have been reported, it’s role in this
subset of patients has not been established.
In conclusion, bleeding portal hypertension of
mixed etiology (intra and extrahepatic) is a rare
condition and devascularization procedures
don’t offer a good long term result.
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COMMENTARY
The issue of treating patients affected by
cirrhosis, upper G. I. bleeding and splenomeso-
portal thrombosis still remains an unsolved
problem due to the severity of combined pre
and intrahepatic portal hypertension. The nice
Mercado experience showed how this modified
Sugiura-Futagawa operation in patients with
relatively good hepatic function (Child A-B)
was partially unsuccessfull due to the high
perioperative and medium term mortality.
However, the lack of a randomized clinical trial
comparing this therapeutric approach to the
"natural history" of these patients, makes every
comment unopportune. It is probably a certai-
nity that the role of T.I.P.S.S. as well that of
shunt surgery is negligible.
On the contrary, we believe that the field of
transplantation will possibly find an acceptable
terapeutic solution for these patients. Recently,
Andreas Tzakis described a new technique for
liver transplantation in presence of complete
splenomesoportal thrombosis using a "caval
transposition". In short, the venous inflow to
the graft is obtained by a cavo-portal anastomo-
sis performed after interruption of the IVC
above the renal veins. This technique may not
improve the portal hypertension; oppositely,
after the operation the patient may experience
a worsening of portal hypertension due to the
increased pressures in the IVC. However, after
the transplant these patients shift from a severe
pre and intrahepatic portal hypertension with
impaired hepatic function, to a severe pre-
hepatic hypertension associated with normal
intraportal pressures and improved liver func-
tion. Therefore, we can theoretically conclude
that in these patients the association of a
Sugiura-Futagawa procedure (or other decon-
nection procedures) to liver transplantation
might be better tolerated thanks to the basically
normal function of the new liver. Such an
association might be excuted in one or more
steps depending on the clinical conditions of the
patients at the time of transplantion. At present,
of course, some more studies are needed.
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Mercado et al., describe their experience with a
difficult topic, i.e., the surgical treatment of
portal hypertension in cirrhotic patients with
complete splenomesoportal thrombosis. In such
a setting, the therapy used by the authors carries
a high mortality rate and also a high morbidity
rate. However, experience in the literature
remains limited due to the rarity of these
patients.
Through their experience, two main points
deserve comments.
First, what is the pathophysiology of portal
hypertension in these patients? The answer to
this question should provide on explanation to
understand why in a subgroup of patients
surgery carries a good prognosis, conversely,
this answer should also allow selection of other
therapies for patients carrying a poor prognosis.
Second, the absence of trials including variceal
banding in such patients must be addressed in
view of the data provided by Mercado et al.
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